A practice guide for continuous opioid therapy for refractory daily headache: Patient selection, physician requirements, and treatment monitoring

Headache

Volumn 50, Issue 7, 2010, Pages 1175-1193

  Saper, Joel R ^a   Lake III, Alvin E ^a   Bain, Philip A ^b   Stillman, Mark J ^c   Rothrock, John F ^d   Mathew, Ninan T ^e   Hamel, Robert L ^a   Moriarty, Maureen ^f   Tietjen, Gretchen E ^g  

^a Michigan Head Pain and Neurological Institute   (United States)

^b Health System   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d University of Alabama at Birmingham   (United States)

^e Houston Headache Clinic   (United States)

^f Mid Atlantic Headache Institute   (United States)

^g MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

continuous opioid therapy; guidelines; refractory daily headache

Indexed keywords

ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; BUTALBITAL; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; COCAINE; DIAMORPHINE; ERGOT DERIVATIVE; ERGOTAMINE; FENTANYL; HYDROCODONE; HYDROCODONE BITARTRATE PLUS PARACETAMOL; KETOROLAC; METHADONE; MORPHINE; MU OPIATE RECEPTOR ANTAGONIST; NARCOTIC ANALGESIC AGENT; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PETHIDINE; PLACEBO; REMIFENTANIL; RIZATRIPTAN; SEX HORMONE; TRIPTAN DERIVATIVE;

ANXIETY DISORDER; APNEA; BEHAVIOR THERAPY; CHRONIC DAILY HEADACHE; CHRONIC LOW BACK PAIN; CHRONIC NONCANCER PAIN; CHRONIC PAIN; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDUCED HEADACHE; DRUG MONITORING; DRUG OVERDOSE; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISODIC CLUSTER HEADACHE; EVIDENCE BASED MEDICINE; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERALGESIA; INSOMNIA; LOW BACK PAIN; MEDICAL SOCIETY; MENTAL DISEASE; META ANALYSIS; MIGRAINE; NAUSEA; NEUROPATHIC PAIN; NOCICEPTION; NOTE; OPIATE ADDICTION; OPIOID INDUCED HYPERALGESIA; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT SELECTION; PHYSICIAN; POSTOPERATIVE PAIN; PRACTICE GUIDELINE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; QT PROLONGATION; RESPIRATION DEPRESSION; RISK FACTOR; SEX HORMONE BLOOD LEVEL; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER; SUDDEN DEATH; SYSTEMATIC REVIEW; TABLET FORMULATION; TERATOGENICITY; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; VOMITING;

ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG RESISTANCE; HEADACHE DISORDERS; HUMANS; OPIOID-RELATED DISORDERS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; TREATMENT OUTCOME;

EID: 77955704587     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2010.01733.x     Document Type: Note

References (129)

1. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: The TROUP study. Pain. 2008 138:440 449.
2. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000. Pain. 2004 109:514 519.
3. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006 7:225 235.
4. Teichtahl H, Wang D. Sleep-disordered breathing with chronic opioid use. Expert Opin Drug Saf. 2007 6:641 649.
5. Cicero TJ, Wong G, Tian Y, Lynskey M, Todorov A, Isenberg K. Co-morbidity and utilization of medical services by pain patients receiving opioid medications: Data from an insurance claims database. Pain. 2009 144:20 27.
6. Partnership for a Drug-Free America. The Partnership Attitude Tracking Study (PATS): Teens 2008 Report. 2009. Available at: http://www.drugfree.org/ Files/full-report-teens-2008. Accessed March 7, 2010.
7. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the future. National results on adolexcent drug use: Overview of key findings, 2008. Vol NIH Publication No. 09-7401. Bethesda, MD: National Institute on Drug Abuse 2009. Accessed March 7, 2010.
8. Substance Abuse and Mental Health Services Administration. Results from the 2006 national survey on drug use and health: National findings. Vol NSDUH Series H-32. DHHS Publication No. SMA 07-4293 ed. Rockville, MD: Department of Health and Human Services, Office of Applied Sutdies 2007. Available at: http://www.oas.samhsa.gov/NSDUH/2k6NSDUH/2k6results.cfm. Accessed March 7, 2010.
9. Warner M, Chen LH, Makus DM, et al. Increase in fatal poisonings involving opioid analgesics in the U.S., 1999-2006. 2009 NCHS Data Brief (No. 22). Accessed March 7, 2010.
10. Stobbe M. In 16 states, drug deaths overtake traffic fatalities. 2009. Available at: http://www.abcnews.go.com. Accessed March 7, 2010.
11. Office of Drug Control Policy. Prescription opioid-related deaths increased 114 percent from 2001-2005, treatment admissions up 74 percent in similar period; young adults hardest hit. 2009. Available at: http://www.ondcp.gov/news/press09/052009.html. Accessed March 7, 2010.
12. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects. CMAJ. 2006 174:1589 1594.
13. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: Systematic review of efficacy and safety. Pain. 2004 112:372 380.
14. Saper JR, Lake AE 3rd., Hamel RL, et al. Daily scheduled opioids for intractable head pain: Long-term observations of a treatment program. Neurology. 2004 62:1687 1694.
15. Saper JR, Lake AE 3rd. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: Limited efficacy, risks, and proposed guidelines. Headache. 2008 48:838 849.
16. Noble M, Tregear SJ, Treadwell JR, Schoelles K. Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety. J Pain Symptom Manage. 2008 35:214 228.
17. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: Opioid treatment for chronic back pain: Prevalence, efficacy, and association with addiction. Ann Intern Med. 2007 146:116 127.
18. Cowan DT, Wilson-Barnett J, Griffiths P, Allan LG. A survey of chronic noncancer pain patients prescribed opioid analgesics. Pain Med. 2003 4:340 351.
19. Cepeda MS, Farrar JT, Baumgarten M, Boston R, Carr DB, Strom BL. Side effects of opioids during short-term administration: Effect of age, gender, and race. Clin Pharmacol Ther. 2003 74:102 112.
20. Katz N, Mazer NA. The impact of opioids on the endocrine system. Clin J Pain. 2009 25:170 175.
21. Vuong C, Van Uum SH, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2009 31:98 132.
22. Meares S, Shores EA, Batchelor J, et al. The relationship of psychological and cognitive factors and opioids in the development of the postconcussion syndrome in general trauma patients with mild traumatic brain injury. J Int Neuropsychol Soc. 2006 12:792 801.
23. Mystakidou K, Tsilika E, Parpa E, Papageorgiou C, Georgaki S, Vlahos L. Investigating the effects of TTS-fentanyl for cancer pain on the psychological status of patients naive to strong opioids: An open label study. Cancer Nurs. 2004 27:127 133.
24. Preter M, Klein DF. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2008 32:603 612.
25. Chapman SL, Byas-Smith MG, Reed BA. Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain. 2002 18 (Suppl. 4 S83 S90.
26. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007 3:455 461.
27. Zgierska A, Brown RT, Zuelsdorff M, Brown D, Zhang Z, Fleming MF. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: A cross-sectional study. J Opioid Manag. 2007 3:317 327.
28. Lucas CE, Vlahos AL, Ledgerwood AM. Kindness kills: The negative impact of pain as the fifth vital sign. J Am Coll Surg. 2007 205:101 107.
29. Chugh SS, Socoteanu C, Reinier K, Waltz J, Jui J, Gunson K. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am J Med. 2008 121:66 71.
30. Food and Drug Administration, Public Health Service, Department of Health and Human Services. Death, narcotic overdose, and serious cardiac arrhythmias: Information for healthcare professionals on methadone. J Pain Palliat Care Pharmacother. 2007 21:69 71.
31. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982 33:335 341.
32. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: Analysis of factors. Headache. 1982 22:66 68.
33. Saper JR. Headache Disorders. Boston, MA:PSG Publishers 1983.
34. Rapoport AM, Weeks R, Sheftell F. Analgesic rebound. Theoretical and practical implications. Cephalalgia. 1985 5 (Suppl. 3 448 450.
35. Scher AI, Lipton RB, Stewart WF, Bigal M. Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study. Cephalalgia. 2010 30:321 328.
36. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008 71:1821 1828.
37. Bigal ME, Lipton RB. Excessive opioid use and the development of chronic migraine. Pain. 2009 142:179 182.
38. Olesen J. The international classification of headache disorders. 2nd edn. (ICHD-II). Rev Neurol (Paris). 2005 161:689 691.
39. Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009 10:113 130.
40. Saper JR, Hamel RL, Lake AE 3rd., Lutz TE, Branca B, Sims D. Long-term scheduled opioid treatment for refractory headache: Second interim outcome report. Headache. 1998 38:401 402 Abstract).
41. Saper JR, Hamel RL, Lake AE 3rd., Lutz TE, Sims D, Branca B. Structured opioid maintenance therapy for refractory chronic headache. Headache. 1997 37:329 Abstract).
42. Saper JR, Lake AE 3rd., Hamel RL, Lutz TE, Branca B, Sims D. Long-term scheduled opioid treatment for intractable headache: Third year outcome of a five year study. Headache. 1999 39:380 Abstract).
43. Saper JR, Lake AE 3rd., Hamel RL, Lutz TE, Branca B, Sims D. Long-term scheduled opioid treatment for intractable headache: 3-year outcome report. Headache. 2000 20:380 Abstract).
44. Rothrock J. Methadone therapy in refractory chronic migraine. Headache. 2005 45:830 Abstract).
45. Jerome A, Pain GRT. Disability Index: Construct and discriminant validity. Arch Phys Med Rehabil. 1991 72:920 922.
46. Tait RC, Chibnall JT, Krause S. The pain disability index: Psychometric properties. Pain. 1990 40:171 182.
47. Tait RC, Pollard CA, Margolis RB, Duckro PN, Krause SJ. The pain disability index: Psychometric and validity data. Arch Phys Med Rehabil. 1987 68:438 441.
48. Breivik H. Opioids in chronic non-cancer pain, indications and controversies. Eur J Pain. 2005 9:127 130.
49. Devulder J, Jacobs A, Richarz U, Wiggett H. Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain. Br J Anaesth. 2009 103:576 585.
50. Eisenberg E, McNicol ED, Carr DB. Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials. Eur J Pain. 2006 10:667 676.
51. Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin. 2007 23:117 128.
52. Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009 91:919 927.
53. Volinn E, Fargo JD, Fine PG. Opioid therapy for nonspecific low back pain and the outcome of chronic work loss. Pain. 2009 142:194 201.
54. Eriksen J, Sjogren P, Bruera E, Ekholm O, Rasmussen NK. Critical issues on opioids in chronic non-cancer pain: An epidemiological study. Pain. 2006 125:172 179.
55. Buntin-Mushock C, Phillip L, Moriyama K, Palmer PP. Age-dependent opioid escalation in chronic pain patients. Anesth Analg. 2005 100:1740 1745.
56. Wang Y, Mitchell J, Moriyama K, et al. Age-dependent morphine tolerance development in the rat. Anesth Analg. 2005 100:1733 1739.
57. Riley JL 3rd., Hastie BA. Individual differences in opioid efficacy for chronic noncancer pain. Clin J Pain. 2008 24:509 520.
58. Angst MS, Clark JD. Opioid-induced hyperalgesia: A qualitative systematic review. Anesthesiology. 2006 104:570 587.
59. Mao J. Opioid-induced abnormal pain sensitivity. Curr Pain Headache Rep. 2006 10:67 70.
60. Ossipov MH, Lai J, King T, et al. Antinociceptive and nociceptive actions of opioids. J Neurobiol. 2004 61:126 148.
61. Mitra S. Opioid-induced hyperalgesia: Pathophysiology and clinical implications. J Opioid Manag. 2008 4:123 130.
62. Celerier E, Gonzalez JR, Maldonado R, Cabanero D, Puig MM. Opioid-induced hyperalgesia in a murine model of postoperative pain: Role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology. 2006 104:546 555.
63. Liang DY, Liao G, Wang J, et al. A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology. 2006 104:1054 1062.
64. Trang T, Quirion R, Jhamandas K. The spinal basis of opioid tolerance and physical dependence: Involvement of calcitonin gene-related peptide, substance P, and arachidonic acid-derived metabolites. Peptides. 2005 26:1346 1355.
65. Trang T, Sutak M, Jhamandas K. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neuroscience. 2007 146:1275 1288.
66. King T, Gardell LR, Wang R, et al. Role of NK-1 neurotransmission in opioid-induced hyperalgesia. Pain. 2005 116:276 288.
67. Vera-Portocarrero LP, Zhang ET, King T, et al. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain. 2007 129:35 45.
68. Simonin F, Schmitt M, Laulin JP, et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA. 2006 103:466 471.
69. Xie JY, Herman DS, Stiller CO, et al. Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance. J Neurosci. 2005 25:409 416.
70. Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: Mechanisms of activation and implications for opioid analgesia, dependence, and reward. ScientificWorldJournal. 2007 7:98 111.
71. Watkins LR, Hutchinson MR, Johnston IN, Mauer SF. Glial novel counter-regulators of opioid analgesia. Trends Neurosci. 2005 12:661 669.
72. Watkins LR, Milligan ED, Maier SF. Glial activation: A driving force for pathological pain. Trends Neurosci. 2001 24:450 455.
73. Tegeder I, Geisslinger G. Opioids as modulators of cell death and survival - unraveling mechanisms and revealing new indications. Pharmacol Rev. 2004 56:351 369.
74. Ram KC, Eisenberg E, Haddad M, Pud D. Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain - new perspective of opioid-induced hyperalgesia. Pain. 2008 139:431 438.
75. Silverman SM. Opioid induced hyperalgesia: Clinical implications for the pain practitioner. Pain Physician. 2009 12:679 684.
76. Vardanyan A, Wang R, Vanderah TW, et al. TRPV1 receptor in expression of opioid-induced hyperalgesia. J Pain. 2009 10:243 252.
77. Porreca F. How pain becomes chronic: Descending (ascending) facilitation. 50th Annual Scientific Meeting of the American Headache Society. Philadelphia, PA, 2009. Available at: http://www.americanheadachesociety.org/ professionalresources/Highlights.asp. Accessed March 7, 2010.
78. Capobianco DJ, Swanson JW, Dodick DW. Medication-induced (analgesic rebound) headache: Historical aspects and initial descriptions of the North American experience. Headache. 2001 41:500 502.
79. Dodick D, Freitag F. Evidence-based understanding of medication-overuse headache: Clinical implications. Headache. 2006 46 (Suppl. 4 S202 S211.
80. Zwart JA, Dyb G, Hagen K, Svebak S, Holmen J. Analgesic use: A predictor of chronic pain and medication overuse headache: The Head-HUNT Study. Neurology. 2003 61:160 164.
81. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache. 2001 41:303 309.
82. Katsarava Z, Jensen R. Medication-overuse headache: Where are we now? Curr Opin Neurol. 2007 20:326 330.
83. Bigal ME, Lipton RB. Modifiable risk factors for migraine progression. Headache. 2006 46:1334 1343.
84. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 26:742 746.
85. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia. 2006 26:1192 1198.
86. Warner JS. The outcome of treating patients with suspected rebound headache. Headache. 2001 41:685 692.
87. Lake AE 3rd., Saper JR, Hamel RL. Comprehensive inpatient treatment of refractory chronic daily headache. Headache. 2009 49:555 562.
88. Altieri M, Di Giambattista R, Di Clemente L, et al. Combined pharmacological and short-term psychodynamic psychotherapy for probable medication overuse headache: A pilot study. Cephalalgia. 2009 29:293 299.
89. Andrasik F, Buse DC, Grazzi L. Behavioral medicine for migraine and medication overuse headache. Curr Pain Headache Rep. 2009 13:241 248.
90. Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM. Discontinuation of medication overuse in headache patients: Recovery of therapeutic responsiveness. Cephalalgia. 2007 27:568. Author reply 568-569.
91. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: Predictors of outcome 1 year after withdrawal therapy. Eur J Neurol. 2009 16:705 712.
92. Boe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: A randomized follow-up by neurologist or PCP. Cephalalgia. 2009 29:855 863.
93. Hagen K, Albretsen C, Vilming ST, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009 29:221 232.
94. Radat F, Creac'h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 48:1026 1036.
95. Rossi P, Faroni JV, Nappi G. Medication overuse headache: Predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008 28:1196 1200.
96. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: A 1-year follow-up study (care II protocol). Cephalalgia. 2010 30:329 336.
97. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, et al. Medication overuse headache: Clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007 27:1219 1225.
98. Townsend CO, Kerkvliet JL, Bruce BK, et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: Comparison of treatment outcomes based on opioid use status at admission. Pain. 2008 140:177 189.
99. Mathew NT, Kurman R, Perez F. Drug induced refractory headache - clinical features and management. Headache. 1990 30:634 638.
100. Grazzi L, Andrasik F. Medication-overuse headache: Description, treatment, and relapse prevention. Curr Pain Headache Rep. 2006 10:71 77.
101. Grazzi L, Andrasik F, D'Amico D, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: Outcome at 3 years. Headache. 2002 42:483 490.
102. Ho TW, Rodgers A, Bigal ME. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis. Headache. 2009 49:395 403.
103. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005 45:850 861.
104. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008 11 (Suppl. 2 S105 S120.
105. Cronin A, Keifer JC, Baghdoyan HA, Lydic R. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist. Br J Anaesth. 1995 74:188 192.
106. Fadda P, Martellotta MC, De Montis MG, Gessa GL, Fratta W. Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats. Neurochem Int. 1992 20:153S 156S.
107. Fadda P, Tortorella A, Fratta W. Sleep deprivation decreases mu and delta opioid receptor binding in the rat limbic system. Neurosci Lett. 1991 129:315 317.
108. Castro MM, Daltro C. Sleep patterns and symptoms of anxiety and depression in patients with chronic pain. Arq Neuropsiquiatr. 2009 67:25 28.
109. Green CR, Ndao-Brumblay SK, Hart-Johnson T. Sleep problems in a racially diverse chronic pain population. Clin J Pain. 2009 25:423 430.
110. Marin R, Cyhan T, Miklos W. Sleep disturbance in patients with chronic low back pain. Am J Phys Med Rehabil. 2006 85:430 435.
111. Marty M, Rozenberg S, Duplan B, Thomas P, Duquesnoy B, Allaert F. Quality of sleep in patients with chronic low back pain: A case-control study. Eur Spine J. 2008 17:839 844.
112. Power JD, Perruccio AV, Badley EM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum. 2005 53:911 919.
113. Brennan MJ, Lieberman JA 3rd. Sleep disturbances in patients with chronic pain: Effectively managing opioid analgesia to improve outcomes. Curr Med Res Opin. 2009 25:1045 1055.
114. Turk DC, Cohen MJ. Sleep as a marker in the effective management of chronic osteoarthritis pain with opioid analgesics. Semin Arthritis Rheum. 2009 39:477 490.
115. Webster LR, Choi Y, Desai H, Webster L, Grant BJ. Sleep-disordered breathing and chronic opioid therapy. Pain Med. 2008 9:425 432.
116. Alattar MA, Scharf SM. Opioid-associated central sleep apnea: A case series. Sleep Breath. 2009 13:201 206.
117. Farney RJ, Walker JM, Boyle KM, Cloward TV, Shilling KC. Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain. J Clin Sleep Med. 2008 4:311 319.
118. Ramar K. Reversal of sleep-disordered breathing with opioid withdrawal. Pain Pract. 2009 9:394 398.
119. Wolff K. Characterization of methadone overdose: Clinical considerations and the scientific evidence. Ther Drug Monit. 2002 24:457 470.
120. Cole BE. Neuroendocrine implications of opioid therapy. Curr Pain Headache Rep. 2007 11:89 92.
121. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain. 2008 9:28 36.
122. Daniell HW. DHEAS deficiency during consumption of sustained-action prescribed opioids: Evidence for opioid-induced inhibition of adrenal androgen production. J Pain. 2006 7:901 907.
123. Hammer RP Jr., Ricalde AA, Seatriz JV. Effects of opiates on brain development. Neurotoxicology. 1989 10:475 483.
124. Bunikowski R, Grimmer I, Heiser A, Metze B, Schafer A, Obladen M. Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr. 1998 157:724 730.
125. Moe V. Foster-placed and adopted children exposed in utero to opiates and other substances: Prediction and outcome at four and a half years. J Dev Behav Pediatr. 2002 23:330 339.
126. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain. 2005 119:95 103.
127. Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 31:564 570.
128. Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag. 2007 3:89 100.
129. Wilsey BL, Fishman SM, Tsodikov A, Ogden C, Symreng I, Ernst A. Psychological comorbidities predicting prescription opioid abuse among patients in chronic pain presenting to the emergency department. Pain Med. 2008 9:1107 1117.